Jasper Therapeutics (JSPR) Tax Provisions (2020)

Jasper Therapeutics (JSPR) posted quarterly Tax Provisions of -$9962.0 for Q4 2020, down 224.52% quarter-over-quarter from $8000.0 in Q3 2020.

Jasper Therapeutics (JSPR) Tax Provisions (2020) Analysis & Trends

Jasper Therapeutics' Tax Provisions history runs 1 years deep, the most recent figure standing at -$9962.0 for Q4 2020.

In Q4 2020, Tax Provisions changed N/A year-over-year to -$9962.0; the TTM figure through Dec 2020 stood at $54666.0 (changed N/A YoY), while the FY2020 annual figure was $38451.0, up 136.99% from the prior year.
Tax Provisions for Q4 2020 stood at -$9962.0, down from $8000.0 in the prior quarter.
The five-year high for Tax Provisions was $57823.0 in Q1 2020, with the low at -$9962.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	59.00 Mn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	13.31 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	1.90 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-90.33 Mn
10	Jasper Therapeutics	20.06 Mn	20.06 Mn	-	-

Download Data